Press Release Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights 11 hours ago
Press Release Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) 11 hours ago